Abstract
In this study, a bioguided fractionation ofPlectranthus mutabilisextract was performed by chromatographicmethods. It yielded one newnor-abietane diterpene, mutabilol (1),and three known abietanes, coleon-U-quinone (2), 8 alpha,9 alpha-epoxycoleon-U-quinone (3), and coleon U (4). The abietanediterpenoid5was also tentatively identified using HPLC-MS/MS.Moreover, the extract profile and quantification of each isolatedcompound were determined by HPLC-DAD. Compound4was themajor compound in the extract. Compounds2-4were found to beselective toward cancer cell lines and were able to inhibit P-glycoprotein (P-gp) activity in NCI-H460/R cells at longerexposure of 72 h and consequently revert doxorubicin (DOX)resistance in subsequent combined treatment. None of thecompounds influenced the P-gp expression in NCI-H460/R cells, while the extract significantly increased it
| Original language | English |
|---|---|
| Pages (from-to) | 674-680 |
| Number of pages | 7 |
| Journal | Acs Medicinal Chemistry Letters |
| Volume | 13 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 14 Apr 2022 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- P-glycoprotei
- Plectranthus mutabilis
- Abietane diterpenoids
- Anticancer effect
- Multidrug resistance
Fingerprint
Dive into the research topics of 'C20-nor-Abietane and Three Abietane Diterpenoids from Plectranthus mutabilis Leaves as P-Glycoprotein Modulators'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver